• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

非小细胞肺癌中 EGFR 突变的放射组学检测。

Radiomic Detection of EGFR Mutations in NSCLC.

机构信息

Lung Cancer Unit, IRCCS Ospedale Policlinico San Martino, Genova, Italy.

Dipartimento di Scienze Mediche, Chirurgiche e Sperimentali, Università degli Studi di Sassari, Sassari, Italy.

出版信息

Cancer Res. 2021 Feb 1;81(3):724-731. doi: 10.1158/0008-5472.CAN-20-0999. Epub 2020 Nov 4.

DOI:10.1158/0008-5472.CAN-20-0999
PMID:33148663
Abstract

Radiomics is defined as the use of automated or semi-automated post-processing and analysis of multiple features derived from imaging exams. Extracted features might generate models able to predict the molecular profile of solid tumors. The aim of this study was to develop a predictive algorithm to define the mutational status of EGFR in treatment-naïve patients with advanced non-small cell lung cancer (NSCLC). CT scans from 109 treatment-naïve patients with NSCLC (21 -mutant and 88 -wild type) underwent radiomics analysis to develop a machine learning model able to recognize -mutant from -WT patients via CT scans. A "test-retest" approach was used to identify stable radiomics features. The accuracy of the model was tested on an external validation set from another institution and on a dataset from the Cancer Imaging Archive (TCIA). The machine learning model that considered both radiomic and clinical features (gender and smoking status) reached a diagnostic accuracy of 88.1% in our dataset with an AUC at the ROC curve of 0.85, whereas the accuracy values in the datasets from TCIA and the external institution were 76.6% and 83.3%, respectively. Furthermore, 17 distinct radiomics features detected at baseline CT scan were associated with subsequent development of T790M during treatment with an EGFR inhibitor. In conclusion, our machine learning model was able to identify -mutant patients in multiple validation sets with globally good accuracy, especially after data optimization. More comprehensive training sets might result in further improvement of radiomics-based algorithms. SIGNIFICANCE: These findings demonstrate that data normalization and "test-retest" methods might improve the performance of machine learning models on radiomics images and increase their reliability when used on external validation datasets.

摘要

放射组学是指使用自动化或半自动化的后处理和分析技术,从影像检查中提取多个特征。提取的特征可能会生成能够预测实体瘤分子谱的模型。本研究旨在开发一种预测算法,以定义初治的晚期非小细胞肺癌(NSCLC)患者中 EGFR 的突变状态。对 109 例初治 NSCLC 患者(21 例突变和 88 例野生型)的 CT 扫描进行放射组学分析,以开发一种能够通过 CT 扫描识别突变型和野生型患者的机器学习模型。采用“测试-再测试”方法来识别稳定的放射组学特征。该模型的准确性在另一个机构的外部验证集和癌症成像档案(TCIA)的数据集中进行了测试。考虑到放射组学和临床特征(性别和吸烟状况)的机器学习模型在我们的数据集上的诊断准确性为 88.1%,ROC 曲线下的 AUC 为 0.85,而 TCIA 和外部机构数据集的准确性值分别为 76.6%和 83.3%。此外,在接受 EGFR 抑制剂治疗期间,基线 CT 扫描上检测到的 17 个独特的放射组学特征与随后发生 T790M 相关。总之,我们的机器学习模型能够在多个验证集中以全球良好的准确性识别突变型患者,尤其是在数据优化后。更全面的训练集可能会进一步提高基于放射组学的算法的性能。意义:这些发现表明,数据归一化和“测试-再测试”方法可能会提高机器学习模型在放射组学图像上的性能,并在应用于外部验证数据集时提高其可靠性。

相似文献

1
Radiomic Detection of EGFR Mutations in NSCLC.非小细胞肺癌中 EGFR 突变的放射组学检测。
Cancer Res. 2021 Feb 1;81(3):724-731. doi: 10.1158/0008-5472.CAN-20-0999. Epub 2020 Nov 4.
2
Next-Generation Radiogenomics Sequencing for Prediction of EGFR and KRAS Mutation Status in NSCLC Patients Using Multimodal Imaging and Machine Learning Algorithms.使用多模态成像和机器学习算法的下一代放射基因组学测序预测非小细胞肺癌患者的EGFR和KRAS突变状态
Mol Imaging Biol. 2020 Aug;22(4):1132-1148. doi: 10.1007/s11307-020-01487-8.
3
Machine Learning-Based Radiomics Signatures for EGFR and KRAS Mutations Prediction in Non-Small-Cell Lung Cancer.基于机器学习的放射组学特征预测非小细胞肺癌中 EGFR 和 KRAS 突变。
Int J Mol Sci. 2021 Aug 26;22(17):9254. doi: 10.3390/ijms22179254.
4
Habitat radiomics and deep learning fusion nomogram to predict EGFR mutation status in stage I non-small cell lung cancer: a multicenter study.基于影像组学和深度学习融合列线图预测Ⅰ期非小细胞肺癌中 EGFR 突变状态:一项多中心研究。
Sci Rep. 2024 Jul 10;14(1):15877. doi: 10.1038/s41598-024-66751-1.
5
Usefulness of gradient tree boosting for predicting histological subtype and EGFR mutation status of non-small cell lung cancer on F FDG-PET/CT.基于 F-FDG-PET/CT 预测非小细胞肺癌组织学分型和表皮生长因子受体突变状态的梯度提升树模型的效用。
Ann Nucl Med. 2020 Jan;34(1):49-57. doi: 10.1007/s12149-019-01414-0. Epub 2019 Oct 28.
6
Value of pre-therapy F-FDG PET/CT radiomics in predicting EGFR mutation status in patients with non-small cell lung cancer.治疗前F-FDG PET/CT影像组学在预测非小细胞肺癌患者表皮生长因子受体(EGFR)突变状态中的价值
Eur J Nucl Med Mol Imaging. 2020 May;47(5):1137-1146. doi: 10.1007/s00259-019-04592-1. Epub 2019 Nov 14.
7
Radiogenomic Models Using Machine Learning Techniques to Predict EGFR Mutations in Non-Small Cell Lung Cancer.基于机器学习技术的放射组学模型预测非小细胞肺癌的 EGFR 突变。
Can Assoc Radiol J. 2021 Feb;72(1):109-119. doi: 10.1177/0846537119899526. Epub 2020 Feb 17.
8
Using contrast-enhanced CT and non-contrast-enhanced CT to predict EGFR mutation status in NSCLC patients-a radiomics nomogram analysis.使用对比增强 CT 和非对比增强 CT 预测 NSCLC 患者的 EGFR 突变状态——放射组学列线图分析。
Eur Radiol. 2022 Apr;32(4):2693-2703. doi: 10.1007/s00330-021-08366-y. Epub 2021 Nov 22.
9
A novel radiomic nomogram for predicting epidermal growth factor receptor mutation in peripheral lung adenocarcinoma.一种用于预测周围型肺腺癌表皮生长因子受体突变的新型放射组学列线图。
Phys Med Biol. 2020 Mar 6;65(5):055012. doi: 10.1088/1361-6560/ab6f98.
10
Radiomics signature: A potential and incremental predictor for EGFR mutation status in NSCLC patients, comparison with CT morphology.放射组学特征:非小细胞肺癌患者表皮生长因子受体突变状态的潜在、增量预测指标,与 CT 形态学比较。
Lung Cancer. 2019 Jun;132:28-35. doi: 10.1016/j.lungcan.2019.03.025. Epub 2019 Mar 26.

引用本文的文献

1
Prediction of oncogene mutation status in non-small cell lung cancer: a systematic review and meta-analysis with a special focus on artificial intelligence-based methods.非小细胞肺癌中癌基因突变状态的预测:一项系统综述和荟萃分析,特别关注基于人工智能的方法
Eur Radiol. 2025 Sep 8. doi: 10.1007/s00330-025-11962-x.
2
Lung metastases.肺转移瘤。
Nat Rev Dis Primers. 2025 Aug 21;11(1):60. doi: 10.1038/s41572-025-00642-1.
3
Machine learning approaches for EGFR mutation status prediction in NSCLC: an updated systematic review.用于非小细胞肺癌中表皮生长因子受体突变状态预测的机器学习方法:一项更新的系统评价
Front Oncol. 2025 Jul 10;15:1576461. doi: 10.3389/fonc.2025.1576461. eCollection 2025.
4
Progress and challenges of artificial intelligence in lung cancer clinical translation.人工智能在肺癌临床转化中的进展与挑战
NPJ Precis Oncol. 2025 Jul 1;9(1):210. doi: 10.1038/s41698-025-00986-7.
5
A multimodal fusion system predicting survival benefits of immune checkpoint inhibitors in unresectable hepatocellular carcinoma.一种预测免疫检查点抑制剂对不可切除肝细胞癌生存获益的多模态融合系统。
NPJ Precis Oncol. 2025 Jun 14;9(1):185. doi: 10.1038/s41698-025-00979-6.
6
Prognostic effect of CD74 and development of a radiomic model for predicting CD74 expression in non-small cell lung cancer.CD74的预后作用及预测非小细胞肺癌中CD74表达的放射组学模型的建立
Front Med (Lausanne). 2025 May 21;12:1586253. doi: 10.3389/fmed.2025.1586253. eCollection 2025.
7
MIPD: Molecules, Imagings, and Clinical Phenotype Integrated Database.MIPD:分子、成像与临床表型综合数据库。
Database (Oxford). 2025 Apr 21;2025. doi: 10.1093/database/baaf029.
8
AI models for the identification of prognostic and predictive biomarkers in lung cancer: a systematic review and meta-analysis.用于识别肺癌预后和预测生物标志物的人工智能模型:系统评价与荟萃分析
Front Oncol. 2025 Feb 26;15:1424647. doi: 10.3389/fonc.2025.1424647. eCollection 2025.
9
Machine Learning and Computed Tomography Radiomics to Predict Disease Progression to Upfront Pembrolizumab Monotherapy in Advanced Non-Small-Cell Lung Cancer: A Pilot Study.机器学习与计算机断层扫描影像组学预测晚期非小细胞肺癌一线帕博利珠单抗单药治疗疾病进展的初步研究
Cancers (Basel). 2024 Dec 28;17(1):58. doi: 10.3390/cancers17010058.
10
A predictive nomogram for mutation status in lung adenocarcinoma manifesting as ground-glass nodules.一种用于表现为磨玻璃结节的肺腺癌突变状态的预测列线图。
J Thorac Dis. 2024 Nov 30;16(11):7477-7489. doi: 10.21037/jtd-24-1166. Epub 2024 Nov 18.